Brief: Ainos Announces Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome
23/09/2024 14:41
Sept 23 (Reuters) - Ainos Inc AIMD.O :
* AINOS INC: PLAN TO INITIATE TAIWAN CLINICAL STUDY OF
VELDONA FOR
TREATING SJÖGREN'S SYNDROME, A RARE DISEASE WITH LIMITED
TREATMENT OPTIONS
* AINOS INC: AIMS TO COMPLETE ALL REGULATORY APPROVALS FOR
STUDY
IN Q4 2024
Further company coverage: AIMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ainos
See all newsAinos Q1 loss narrows as costs fall
Brief: Ainos On Dec 30 2025, Enters Distribution Agreement With Trusval Technology
Brief: Ainos Inc Receives IRB Approval From National Taiwan University Hospital For Hiv-Oral Warts Clinical Trial
Brief: Ainos Announces Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome
Brief: Ainos Secures Taiwan Invention Patent And Advances Global Patent Protection For Veldona